{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:30:10Z","timestamp":1764001810827},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T00:00:00Z","timestamp":1312588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00774-011-0298-0","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T06:15:14Z","timestamp":1312524914000},"page":"507-514","source":"Crossref","is-referenced-by-count":40,"title":["Fibroblast growth factor 23 as a phosphotropic hormone and beyond"],"prefix":"10.1007","volume":"29","author":[{"given":"Seiji","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,6]]},"reference":[{"key":"298_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"The ADHR Consortium","year":"2000","unstructured":"The ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"298_CR2","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"298_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","volume":"20","author":"S Fukumoto","year":"2009","unstructured":"Fukumoto S, Martin TJ (2009) Bone as an endocrine organ. Trends Endocrinol Metab 20:230\u2013236","journal-title":"Trends Endocrinol Metab"},{"key":"298_CR4","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205\u20132215","journal-title":"J Am Soc Nephrol"},{"key":"298_CR5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78:975\u2013980","journal-title":"Kidney Int"},{"key":"298_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"298_CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"298_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421\u2013432","journal-title":"Matrix Biol"},{"key":"298_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351","journal-title":"Nature"},{"key":"298_CR10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1210\/en.143.2.683","volume":"143","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Fujimori T, Nabeshima Y (2002) Mediation of unusually high concentrations of 1, 25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143:683\u2013689","journal-title":"Endocrinology"},{"key":"298_CR11","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","volume":"281","author":"H Kurosu","year":"2006","unstructured":"Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M, Nandi A, Rosenblatt KP, Baum MG, Schiavi S, Hu MC, Moe OW, Kuro-o M (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem 281:6120\u20136123","journal-title":"J Biol Chem"},{"key":"298_CR12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770\u2013774","journal-title":"Nature"},{"key":"298_CR13","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","volume":"19","author":"S Liu","year":"2008","unstructured":"Liu S, Vierthaler L, Tang W, Zhou J, Quarles LD (2008) FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol 19:2342\u20132350","journal-title":"J Am Soc Nephrol"},{"key":"298_CR14","doi-asserted-by":"crossref","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310\u20131315","DOI":"10.1038\/ng1905"},{"key":"298_CR15","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD (2006) Pathogenic role of FGF23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38\u2013E49","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"298_CR16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","volume":"35","author":"M Mirams","year":"2004","unstructured":"Mirams M, Robinson BG, Mason RS, Nelson AE (2004) Bone as a source of FGF23: regulation by phosphate? Bone 35:1192\u20131199","journal-title":"Bone"},{"key":"298_CR17","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","volume":"150","author":"R Samadfam","year":"2009","unstructured":"Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I, Goltzman D (2009) Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150:4835\u20134845","journal-title":"Endocrinology"},{"key":"298_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jmicro\/dfp032","volume":"58","author":"S Ubaidus","year":"2009","unstructured":"Ubaidus S, Li M, Sultana S, de Freitas PH, Oda K, Maeda T, Takagi R, Amizuka N (2009) FGF23 is mainly synthesized by osteocytes in the regularly distributed osteocytic lacunar canalicular system established after physiological bone remodeling. J Electron Microsc (Tokyo) 58:381\u2013392","journal-title":"J Electron Microsc (Tokyo)"},{"key":"298_CR19","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"298_CR20","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87:4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"key":"298_CR21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Juppner H, Strom TM (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38:1248\u20131250","journal-title":"Nat Genet"},{"key":"298_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"V Levy-Litan","year":"2010","unstructured":"Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86:273\u2013278","journal-title":"Am J Hum Genet"},{"key":"298_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","volume":"86","author":"B Lorenz-Depiereux","year":"2010","unstructured":"Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86:267\u2013272","journal-title":"Am J Hum Genet"},{"key":"298_CR24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"298_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.a.30599","volume":"134","author":"WH Hoffman","year":"2005","unstructured":"Hoffman WH, Jueppner HW, Deyoung BR, O\u2019Dorisio MS, Given KS (2005) Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. Am J Med Genet A 134:233\u2013236","journal-title":"Am J Med Genet A"},{"key":"298_CR26","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.143.8.3179","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179\u20133182","journal-title":"Endocrinology"},{"key":"298_CR27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079\u20132086","journal-title":"Kidney Int"},{"key":"298_CR28","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","volume":"94","author":"BJ Schouten","year":"2009","unstructured":"Schouten BJ, Hunt PJ, Livesey JH, Frampton CM, Soule SG (2009) FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 94:2332\u20132337","journal-title":"J Clin Endocrinol Metab"},{"key":"298_CR29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","volume":"45","author":"Y Shimizu","year":"2009","unstructured":"Shimizu Y, Tada Y, Yamauchi M, Okamoto T, Suzuki H, Ito N, Fukumoto S, Sugimoto T, Fujita T (2009) Hypophosphatemia induced by intravenous administration of saccharated ferric oxide\u2014another form of FGF23-related hypophosphatemia. Bone 45:814\u2013816","journal-title":"Bone"},{"key":"298_CR30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients\u2014proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235\u20131239","journal-title":"Bone"},{"key":"298_CR31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/jcem-67-1-88","volume":"67","author":"KW Lyles","year":"1988","unstructured":"Lyles KW, Halsey DL, Friedman NE, Lobauch B (1988) Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis. J Clin Endocrinol Metab 67:88\u201392","journal-title":"J Clin Endocrinol Metab"},{"key":"298_CR32","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya K, Fukumoto S, Backenroth R, Takeuchi Y, Nakayama K, Ito N, Yoshii N, Yamazaki Y, Yamashita T, Silver J, Igarashi T, Fujita T (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90:5523\u20135527","journal-title":"J Clin Endocrinol Metab"},{"key":"298_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pages","year":"2005","unstructured":"Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385\u2013390","journal-title":"Hum Mol Genet"},{"key":"298_CR34","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117:2684\u20132691","journal-title":"J Clin Invest"},{"key":"298_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36:579\u2013581","journal-title":"Nat Genet"},{"key":"298_CR36","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"298_CR37","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","volume":"67","author":"JJ Kazama","year":"2005","unstructured":"Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M (2005) Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 67:1120\u20131125","journal-title":"Kidney Int"},{"key":"298_CR38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","volume":"44","author":"T Shigematsu","year":"2004","unstructured":"Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M (2004) Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44:250\u2013256","journal-title":"Am J Kidney Dis"},{"key":"298_CR39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova T, Gutierrez OM, Smith K, Epstein M, Keating LK, Juppner H, Wolf M (2011) Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant 26:584\u2013591","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519\u20131524","journal-title":"J Clin Endocrinol Metab"},{"key":"298_CR41","doi-asserted-by":"crossref","unstructured":"Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549","DOI":"10.1074\/jbc.M408903200"},{"key":"298_CR42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1542-4758.2010.00480.x","volume":"14","author":"M Balci","year":"2010","unstructured":"Balci M, Kirkpantur A, Gulbay M, Gurbuz OA (2010) Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int 14:425\u2013432","journal-title":"Hemodial Int"},{"key":"298_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5301\/JN.2010.5818","volume":"24","author":"G Coen","year":"2011","unstructured":"Coen G, De Paolis P, Ballanti P, Pierantozzi A, Pisano S, Sardella D, Mantella D, Pellegrino L, Silvestrini G, Iappelli M, Di Giulio S (2011) Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23. J Nephrol 24:313\u2013321","journal-title":"J Nephrol"},{"key":"298_CR44","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Kuen E, Konig P, Kraatz G, Mann JF, Muller GA, Kohler H, Riegler P (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18:2600\u20132608","journal-title":"J Am Soc Nephrol"},{"key":"298_CR45","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, Defilippi C, Wolf M (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552","journal-title":"Circulation"},{"key":"298_CR46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"298_CR47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","volume":"337","author":"HJ Hsu","year":"2009","unstructured":"Hsu HJ, Wu MS (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337:116\u2013122","journal-title":"Am J Med Sci"},{"key":"298_CR48","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00198-006-0154-6","volume":"17","author":"M Inaba","year":"2006","unstructured":"Inaba M, Okuno S, Imanishi Y, Yamada S, Shioi A, Yamakawa T, Ishimura E, Nishizawa Y (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporos Int 17:1506\u20131513","journal-title":"Osteoporos Int"},{"key":"298_CR49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2009) Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant 24:948\u2013955","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR50","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","volume":"24","author":"G Jean","year":"2009","unstructured":"Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 24:2792\u20132796","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR51","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.00950110","volume":"5","author":"N Kanaan","year":"2010","unstructured":"Kanaan N, Claes K, Devogelaer JP, Vanderschueren D, Depresseux G, Goffin E, Evenepoel P (2010) Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss. Clin J Am Soc Nephrol 5:1887\u20131892","journal-title":"Clin J Am Soc Nephrol"},{"key":"298_CR52","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2215\/CJN.02560310","volume":"5","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A (2010) Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 5:1780\u20131786","journal-title":"Clin J Am Soc Nephrol"},{"key":"298_CR53","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gfq539","volume":"26","author":"A Kirkpantur","year":"2011","unstructured":"Kirkpantur A, Balci M, Gurbuz OA, Afsar B, Canbakan B, Akdemir R, Ayli MD (2011) Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients. Nephrol Dial Transplant 26:1346\u20131354","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR54","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","volume":"21","author":"P Manghat","year":"2010","unstructured":"Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G (2010) Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int 21:1853\u20131861","journal-title":"Osteoporos Int"},{"key":"298_CR55","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-008-0780-2","volume":"20","author":"R Marsell","year":"2009","unstructured":"Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellstrom D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE (2009) Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int 20:1167\u20131173","journal-title":"Osteoporos Int"},{"key":"298_CR56","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","volume":"24","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Hansen T, Johansson L, Ahlstrom H, Larsson A, Lind L, Larsson TE (2009) Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 24:3125\u20133131","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jbmr.263","volume":"26","author":"MA Mirza","year":"2011","unstructured":"Mirza MA, Karlsson MK, Mellstrom D, Orwoll E, Ohlsson C, Ljunggren O, Larsson TE (2011) Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men. J Bone Miner Res 26:857\u2013864","journal-title":"J Bone Miner Res"},{"key":"298_CR58","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","volume":"205","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 205:385\u2013390","journal-title":"Atherosclerosis"},{"key":"298_CR59","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207:546\u2013551","journal-title":"Atherosclerosis"},{"key":"298_CR60","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/ndt\/gfq089","volume":"25","author":"MM Nasrallah","year":"2010","unstructured":"Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA (2010) Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 25:2679\u20132685","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR61","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1253\/circj.CJ-10-0355","volume":"74","author":"K Negishi","year":"2010","unstructured":"Negishi K, Kobayashi M, Ochiai I, Yamazaki Y, Hasegawa H, Yamashita T, Shimizu T, Kasama S, Kurabayashi M (2010) Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients. Comparison with B-type natriuretic peptide and cardiac troponin T. Circ J 74:2734\u20132740","journal-title":"Circ J"},{"key":"298_CR62","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/ndt\/gfq191","volume":"25","author":"H Olauson","year":"2010","unstructured":"Olauson H, Qureshi AR, Miyamoto T, Barany P, Heimburger O, Lindholm B, Stenvinkel P, Larsson TE (2010) Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship? Nephrol Dial Transplant 25:3033\u20133038","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR63","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152:640\u2013648","journal-title":"Ann Intern Med"},{"key":"298_CR64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000243050","volume":"32","author":"M Peiskerova","year":"2009","unstructured":"Peiskerova M, Kalousova M, Kratochvilova M, Dusilova-Sulkova S, Uhrova J, Bandur S, Malbohan IM, Zima T, Tesar V (2009) Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Kidney Blood Press Res 32:276\u2013283","journal-title":"Kidney Blood Press Res"},{"key":"298_CR65","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2265.2007.03074.x","volume":"68","author":"M Roos","year":"2008","unstructured":"Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, Braun S, Martinof S, Schomig A, Heemann U, Kastrati A, Hausleiter J (2008) Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) 68:660\u2013665","journal-title":"Clin Endocrinol (Oxf)"},{"key":"298_CR66","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","volume":"25","author":"S Seiler","year":"2010","unstructured":"Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH (2010) FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant 25:3983\u20133989","journal-title":"Nephrol Dial Transplant"},{"key":"298_CR67","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","volume":"26","author":"PR Srivaths","year":"2011","unstructured":"Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED (2011) Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol 26:945\u2013951","journal-title":"Pediatr Nephrol"},{"key":"298_CR68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5551\/jat.5595","volume":"18","author":"N Tamei","year":"2011","unstructured":"Tamei N, Ogawa T, Ishida H, Ando Y, Nitta K (2011) Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis. J Atheroscler Thromb 18:217\u2013223","journal-title":"J Atheroscler Thromb"},{"key":"298_CR69","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","volume":"161","author":"EN Taylor","year":"2011","unstructured":"Taylor EN, Rimm EB, Stampfer MJ, Curhan GC (2011) Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161:956\u2013962","journal-title":"Am Heart J"},{"key":"298_CR70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","volume":"6","author":"SM Titan","year":"2011","unstructured":"Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moyses RM (2011) FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 6:241\u2013247","journal-title":"Clin J Am Soc Nephrol"},{"key":"298_CR71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.ki.5002622","volume":"73","author":"P Urena Torres","year":"2008","unstructured":"Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prie D (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73:102\u2013107","journal-title":"Kidney Int"},{"key":"298_CR72","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","volume":"22","author":"M Wolf","year":"2011","unstructured":"Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, Kiss I, Rosivall L, Kosa J, Lakatos P, Kovesdy CP, Mucsi I (2011) Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol 22:956\u2013966","journal-title":"J Am Soc Nephrol"},{"key":"298_CR73","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305:1119\u20131127","journal-title":"JAMA"},{"key":"298_CR74","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.0000124224.48962.32","volume":"109","author":"K Takeshita","year":"2004","unstructured":"Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, Yasui K, Lee JK, Kamiya K, Kitaichi K, Yamamoto K, Ito M, Kondo T, Iino S, Inden Y, Hirai M, Murohara T, Kodama I, Nabeshima Y (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109:1776\u20131782","journal-title":"Circulation"},{"key":"298_CR75","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ki.2009.24","volume":"75","author":"M Ohnishi","year":"2009","unstructured":"Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009) Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75:1166\u20131172","journal-title":"Kidney Int"},{"key":"298_CR76","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2353\/ajpath.2006.060329","volume":"169","author":"D Sitara","year":"2006","unstructured":"Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, Erben RG, Lanske B (2006) Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161\u20132170","journal-title":"Am J Pathol"},{"key":"298_CR77","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.275","volume":"26","author":"Y Aono","year":"2011","unstructured":"Aono Y, Hasegawa H, Yamazaki Y, Shimada T, Fujita T, Yamashita T, Fukumoto S (2011) Anti-FGF23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice. J Bone Miner Res 26:803\u2013810","journal-title":"J Bone Miner Res"},{"key":"298_CR78","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","volume":"24","author":"Y Aono","year":"2009","unstructured":"Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, Fujita T, Wada M, Yamashita T, Fukumoto S, Shimada T (2009) Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J Bone Miner Res 24:1879\u20131888","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0298-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-011-0298-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0298-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T20:08:46Z","timestamp":1560456526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-011-0298-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,6]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1007\/s00774-011-0298-0","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,6]]}}}